PMAM
ARNA

Picton Mahoney Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Picton Mahoney Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-80,000
Closed -$7.43M – 1213
2021
Q4 		$7.43M Buy
+80,000
New +$5.27M 0.18% 100

Picton Mahoney Asset Management's ARNA Position: Q1 2022 in Review

Picton Mahoney Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 80,000 shares — an estimated $7.43M sold.

Picton Mahoney Asset Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $7.43M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Picton Mahoney Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 80,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $7.43M.
  • Picton Mahoney Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Picton Mahoney Asset Management's Arena Pharmaceuticals Inc position peaked at $7.43M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2022, filed 11 May 2022.